Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
took Paxlovid previously when patient had COVID; took Paxlovid previously when patient had COVID; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "took Paxlovid previously when patient had COVID". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient received Pfizer COVID vaccine for Covid. It was reported that the patient took Paxlovid previously when the patient had COVID. It was unknown if the patient having COVID was before or after having Pfizer COVID vaccine. The patient also wanted to confirm if the Pfizer COVID vaccine and Johnson and Johnson COVID vaccine were the same kind of vaccine. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.